{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:19:38Z","timestamp":1792783178734,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Research Project of Jiangsu Cancer Hospital","award":["ZJ202305"],"award-info":[{"award-number":["ZJ202305"]}],"id":[{"id":"https:\/\/ror.org\/03108sf43","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Jiangsu Province \"The 14th Five-year Plan\" Key Discipline-Public Health and Preventive Medicine","award":["035091005007"],"award-info":[{"award-number":["035091005007"]}]},{"name":"the National Natural Science Foundation of China","award":["81803217"],"award-info":[{"award-number":["81803217"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Research Project of Jiangsu Association of Chinese Medicine","award":["CYTF2026002"],"award-info":[{"award-number":["CYTF2026002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05776-8","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:15:29Z","timestamp":1792077329000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Luteolin inhibits prostate cancer stem cells through disrupting the lactate\/H3K18la\/\u03b2-catenin\/LDHA feedback loop"],"prefix":"10.1007","author":[{"given":"Qi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxiang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanshuang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"key":"5776_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics, 2024. CA Cancer J Clin 74:12\u201349. https:\/\/doi.org\/10.3322\/caac.21820","journal-title":"CA Cancer J Clin"},{"key":"5776_CR2","doi-asserted-by":"publisher","first-page":"7856","DOI":"10.1039\/d0cs00379d","volume":"49","author":"J Han","year":"2020","unstructured":"Han J, Won M, Kim JH, Jung E, Min K, Jangili P, Kim JS (2020) Cancer stem cell-targeted bio-imaging and chemotherapeutic perspective. Chem Soc Rev 49:7856\u20137878. https:\/\/doi.org\/10.1039\/d0cs00379d","journal-title":"Chem Soc Rev"},{"key":"5776_CR3","doi-asserted-by":"publisher","unstructured":"Koukourakis IM, Platoni K, Kouloulias V, Arelaki S, Zygogianni A (2023) Prostate Cancer Stem Cells: Biology and Treatment Implications. Int J Mol Sci 24. https:\/\/doi.org\/10.3390\/ijms241914890","DOI":"10.3390\/ijms241914890"},{"key":"5776_CR4","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s12015-013-9453-4","volume":"9","author":"B Sharpe","year":"2013","unstructured":"Sharpe B, Beresford M, Bowen R, Mitchard J, Chalmers AD (2013) Searching for prostate cancer stem cells: markers and methods. Stem Cell Rev Rep 9:721\u2013730. https:\/\/doi.org\/10.1007\/s12015-013-9453-4","journal-title":"Stem Cell Rev Rep"},{"key":"5776_CR5","doi-asserted-by":"publisher","first-page":"101692","DOI":"10.1016\/j.gendis.2025.101692","volume":"12","author":"G Du","year":"2025","unstructured":"Du G, Huang X, Su P, Yang Y, Chen S, Huang T, Zhang N (2025) The role of SOX transcription factors in prostate cancer: Focusing on SOX2. Genes Dis 12:101692. https:\/\/doi.org\/10.1016\/j.gendis.2025.101692","journal-title":"Genes Dis"},{"key":"5776_CR6","doi-asserted-by":"publisher","first-page":"101689","DOI":"10.1016\/j.gendis.2025.101689","volume":"12","author":"H Wang","year":"2025","unstructured":"Wang H, Liang S, Du X, Zhao G, Bai Y, Li J, Xu H, Peng S, Yuan Y, Tang W (2025) RAB26 promotes prostate cancer progression via the MAPK\/ERK-TWIST1 signaling axis. Genes Dis 12:101689. https:\/\/doi.org\/10.1016\/j.gendis.2025.101689","journal-title":"Genes Dis"},{"key":"5776_CR7","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nrurol.2017.144","volume":"14","author":"V Murillo-Garzon","year":"2017","unstructured":"Murillo-Garzon V, Kypta R (2017) WNT signalling in prostate cancer. Nat Rev Urol 14:683\u2013696. https:\/\/doi.org\/10.1038\/nrurol.2017.144","journal-title":"Nat Rev Urol"},{"key":"5776_CR8","doi-asserted-by":"publisher","unstructured":"Zhou Y, Li T, Jia M, Dai R, Wang R (2023) The Molecular Biology of Prostate Cancer Stem Cells: From the Past to the Future. Int J Mol Sci 24. https:\/\/doi.org\/10.3390\/ijms24087482","DOI":"10.3390\/ijms24087482"},{"key":"5776_CR9","doi-asserted-by":"publisher","first-page":"188887","DOI":"10.1016\/j.bbcan.2023.188887","volume":"1878","author":"P Verma","year":"2023","unstructured":"Verma P, Shukla N, Kumari S, Ansari MS, Gautam NK, Patel GK (2023) Cancer stem cell in prostate cancer progression, metastasis and therapy resistance. Biochim Biophys Acta Rev Cancer 1878:188887. https:\/\/doi.org\/10.1016\/j.bbcan.2023.188887","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"5776_CR10","doi-asserted-by":"publisher","unstructured":"Chetta P, Sriram R, Zadra G (2023) Lactate as Key Metabolite in Prostate Cancer Progression: What Are the Clinical Implications? Cancers (Basel) 15. https:\/\/doi.org\/10.3390\/cancers15133473","DOI":"10.3390\/cancers15133473"},{"key":"5776_CR11","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1017\/erm.2022.42","volume":"25","author":"X Lv","year":"2023","unstructured":"Lv X, Lv Y, Dai X (2023) Lactate, histone lactylation and cancer hallmarks. Expert Rev Mol Med 25:e7. https:\/\/doi.org\/10.1017\/erm.2022.42","journal-title":"Expert Rev Mol Med"},{"key":"5776_CR12","doi-asserted-by":"publisher","first-page":"107753","DOI":"10.1016\/j.pharmthera.2020.107753","volume":"221","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Yu D (2021) Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther 221:107753. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107753","journal-title":"Pharmacol Ther"},{"key":"5776_CR13","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.clgc.2019.07.009","volume":"17","author":"K Mori","year":"2019","unstructured":"Mori K, Kimura S, Parizi MK, Enikeev DV, Glybochko PV, Seebacher V, Fajkovic H, Mostafaei H, Lysenko I, Janisch F, Egawa S, Shariat SF (2019) Prognostic Value of Lactate Dehydrogenase in Metastatic Prostate Cancer: A Systematic Review and Meta-analysis. Clin Genitourin Cancer 17:409\u2013418. https:\/\/doi.org\/10.1016\/j.clgc.2019.07.009","journal-title":"Clin Genitourin Cancer"},{"key":"5776_CR14","doi-asserted-by":"publisher","first-page":"7341","DOI":"10.1002\/cam4.3108","volume":"9","author":"F Li","year":"2020","unstructured":"Li F, Xiang H, Pang Z, Chen Z, Dai J, Chen S, Xu B, Zhang T (2020) Association between lactate dehydrogenase levels and oncologic outcomes in metastatic prostate cancer: A meta-analysis. Cancer Med 9:7341\u20137351. https:\/\/doi.org\/10.1002\/cam4.3108","journal-title":"Cancer Med"},{"key":"5776_CR15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s13059-022-02775-y","volume":"23","author":"E Galle","year":"2022","unstructured":"Galle E, Wong CW, Ghosh A, Desgeorges T, Melrose K, Hinte LC, Castellano-Castillo D, Engl M, de Sousa JA, Ruiz-Ojeda FJ, De Bock K, Ruiz JR, von Meyenn F (2022) H3K18 lactylation marks tissue-specific active enhancers. Genome Biol 23:207. https:\/\/doi.org\/10.1186\/s13059-022-02775-y","journal-title":"Genome Biol"},{"key":"5776_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2024.07.001","author":"P Chai","year":"2024","unstructured":"Chai P, Zhao F, Jia R, Zhou X, Fan X (2024) Lactate\/lactylation in ocular development and diseases. Trends Mol Med. https:\/\/doi.org\/10.1016\/j.molmed.2024.07.001","journal-title":"Trends Mol Med"},{"key":"5776_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41392-024-02082-x","volume":"10","author":"J Chen","year":"2025","unstructured":"Chen J, Huang Z, Chen Y, Tian H, Chai P, Shen Y, Yao Y, Xu S, Ge S, Jia R (2025) Lactate and lactylation in cancer. Signal Transduct Target Ther 10:38. https:\/\/doi.org\/10.1038\/s41392-024-02082-x","journal-title":"Signal Transduct Target Ther"},{"key":"5776_CR18","doi-asserted-by":"publisher","first-page":"108612","DOI":"10.1016\/j.biopha.2019.108612","volume":"112","author":"M Imran","year":"2019","unstructured":"Imran M, Rauf A, Abu-Izneid T, Nadeem M, Shariati MA, Khan IA, Imran A, Orhan IE, Rizwan M, Atif M, Gondal TA, Mubarak MS (2019) Luteolin, a flavonoid, as an anticancer agent: A review. Biomed Pharmacother 112:108612. https:\/\/doi.org\/10.1016\/j.biopha.2019.108612","journal-title":"Biomed Pharmacother"},{"key":"5776_CR19","doi-asserted-by":"publisher","first-page":"9966750","DOI":"10.1155\/2022\/9966750","volume":"2022","author":"M Chagas","year":"2022","unstructured":"Chagas M, Behrens MD, Moragas-Tellis CJ, Penedo GXM, Silva AR, Goncalves-de-Albuquerque CF (2022) Flavonols and Flavones as Potential anti-Inflammatory, Antioxidant, and Antibacterial Compounds. Oxid Med Cell Longev 2022:9966750. https:\/\/doi.org\/10.1155\/2022\/9966750","journal-title":"Oxid Med Cell Longev"},{"key":"5776_CR20","doi-asserted-by":"publisher","unstructured":"Cetinkaya M, Baran Y (2023) Therapeutic Potential of Luteolin on Cancer. Vaccines (Basel) 11. https:\/\/doi.org\/10.3390\/vaccines11030554","DOI":"10.3390\/vaccines11030554"},{"key":"5776_CR21","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1186\/s12935-022-02808-3","volume":"22","author":"P Prasher","year":"2022","unstructured":"Prasher P, Sharma M, Singh SK, Gulati M, Chellappan DK, Zacconi F, De Rubis G, Gupta G, Sharifi-Rad J, Cho WC, Dua K (2022) Luteolin: a flavonoid with a multifaceted anticancer potential. Cancer Cell Int 22:386. https:\/\/doi.org\/10.1186\/s12935-022-02808-3","journal-title":"Cancer Cell Int"},{"key":"5776_CR22","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1111\/bph.15193","volume":"177","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U, Emerson M, Garner P, Holgate ST, Howells DW, Karp NA, Lazic SE, Lidster K, MacCallum CJ, Macleod M, Pearl EJ, Petersen OH, Rawle F, Reynolds P, Rooney K, Sena ES, Silberberg SD, Steckler T, Wurbel H (2020) The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. Br J Pharmacol 177:3617\u20133624. https:\/\/doi.org\/10.1111\/bph.15193","journal-title":"Br J Pharmacol"},{"key":"5776_CR23","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13287-015-0177-z","volume":"6","author":"MI Khan","year":"2015","unstructured":"Khan MI, Czarnecka AM, Helbrecht I, Bartnik E, Lian F, Szczylik C (2015) Current approaches in identification and isolation of human renal cell carcinoma cancer stem cells. Stem Cell Res Ther 6:178. https:\/\/doi.org\/10.1186\/s13287-015-0177-z","journal-title":"Stem Cell Res Ther"},{"key":"5776_CR24","doi-asserted-by":"publisher","first-page":"3981","DOI":"10.1038\/s41467-019-11662-3","volume":"10","author":"Y Fang","year":"2019","unstructured":"Fang Y, Shen ZY, Zhan YZ, Feng XC, Chen KL, Li YS, Deng HJ, Pan SM, Wu DH, Ding Y (2019) CD36 inhibits beta-catenin\/c-myc-mediated glycolysis through ubiquitination of GPC4 to repress colorectal tumorigenesis. Nat Commun 10:3981. https:\/\/doi.org\/10.1038\/s41467-019-11662-3","journal-title":"Nat Commun"},{"key":"5776_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13046-018-0673-y","volume":"37","author":"Q Fan","year":"2018","unstructured":"Fan Q, Yang L, Zhang X, Ma Y, Li Y, Dong L, Zong Z, Hua X, Su D, Li H, Liu J (2018) Autophagy promotes metastasis and glycolysis by upregulating MCT1 expression and Wnt\/beta-catenin signaling pathway activation in hepatocellular carcinoma cells. J Exp Clin Cancer Res 37:9. https:\/\/doi.org\/10.1186\/s13046-018-0673-y","journal-title":"J Exp Clin Cancer Res"},{"key":"5776_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D (2022) Hallmarks of Cancer: New Dimensions. Cancer Discov 12:31\u201346. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-1059","journal-title":"Cancer Discov"},{"key":"5776_CR27","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41392-022-01151-3","volume":"7","author":"X Li","year":"2022","unstructured":"Li X, Yang Y, Zhang B, Lin X, Fu X, An Y, Zou Y, Wang JX, Wang Z, Yu T (2022) Lactate metabolism in human health and disease. Signal Transduct Target Ther 7:305. https:\/\/doi.org\/10.1038\/s41392-022-01151-3","journal-title":"Signal Transduct Target Ther"},{"key":"5776_CR28","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1158\/0008-5472.CAN-21-0914","volume":"82","author":"L Ippolito","year":"2022","unstructured":"Ippolito L, Comito G, Parri M, Iozzo M, Duatti A, Virgilio F, Lorito N, Bacci M, Pardella E, Sandrini G, Bianchini F, Damiano R, Ferrone L, la Marca G, Serni S, Spatafora P, Catapano CV, Morandi A, Giannoni E, Chiarugi P (2022) Lactate Rewires Lipid Metabolism and Sustains a Metabolic-Epigenetic Axis in Prostate Cancer. Cancer Res 82:1267\u20131282. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-0914","journal-title":"Cancer Res"},{"key":"5776_CR29","doi-asserted-by":"publisher","first-page":"4930","DOI":"10.1158\/1078-0432.CCR-23-1441","volume":"29","author":"K Chaudagar","year":"2023","unstructured":"Chaudagar K, Hieromnimon HM, Kelley A, Labadie B, Shafran J, Rameshbabu S, Drovetsky C, Bynoe K, Solanki A, Markiewicz E, Fan X, Loda M, Patnaik A (2023) Suppression of Tumor Cell Lactate-generating Signaling Pathways Eradicates Murine PTEN\/p53-deficient Aggressive-variant Prostate Cancer via Macrophage Phagocytosis. Clin Cancer Res 29:4930\u20134940. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-1441","journal-title":"Clin Cancer Res"},{"key":"5776_CR30","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1158\/1078-0432.CCR-22-3350","volume":"29","author":"K Chaudagar","year":"2023","unstructured":"Chaudagar K, Hieromnimon HM, Khurana R, Labadie B, Hirz T, Mei S, Hasan R, Shafran J, Kelley A, Apostolov E, Al-Eryani G, Harvey K, Rameshbabu S, Loyd M, Bynoe K, Drovetsky C, Solanki A, Markiewicz E, Zamora M, Fan X, Schurer S, Swarbrick A, Sykes DB, Patnaik A (2023) Reversal of Lactate and PD-1-mediated Macrophage Immunosuppression Controls Growth of PTEN\/p53-deficient Prostate Cancer. Clin Cancer Res 29:1952\u20131968. https:\/\/doi.org\/10.1158\/1078-0432.CCR-22-3350","journal-title":"Clin Cancer Res"},{"key":"5776_CR31","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1038\/s41388-026-03737-5","volume":"45","author":"X Wei","year":"2026","unstructured":"Wei X, Li X, Pan Y, Zhang Y, Zhong D, Kong W, Wang Y, Yu Z, Shao W, Dong Y, Jiang S, Qiu Z, Zhang Y, Li X, Li Y, Gu S, Tian C, Qin C, Zhu Q, Feng N, Song N, Yao B, Yang Z (2026) LDHA-driven lactate metabolism promotes MDSC activation and immunosuppressive microenvironment in prostate cancer. Oncogene 45:1544\u20131556. https:\/\/doi.org\/10.1038\/s41388-026-03737-5","journal-title":"Oncogene"},{"key":"5776_CR32","doi-asserted-by":"publisher","first-page":"101227","DOI":"10.1016\/j.neo.2025.101227","volume":"69","author":"Q He","year":"2025","unstructured":"He Q, Li H, Cong Y, Chen K, Cheng L, Lv F, Zhang P, Ju Y, Yu Z, Chen J, Wang C, Song Y, Li X, Chen L, Xing Y (2025) FAM111B enhances glycolysis and promotes metastasis of prostate cancer by upregulating LDHA. Neoplasia 69:101227. https:\/\/doi.org\/10.1016\/j.neo.2025.101227","journal-title":"Neoplasia"},{"key":"5776_CR33","doi-asserted-by":"publisher","first-page":"8771","DOI":"10.2147\/OTT.S258724","volume":"13","author":"T Liang","year":"2020","unstructured":"Liang T, Ye X, Yan D, Deng C, Li Z, Tian B (2020) FAM46B Promotes Apoptosis and Inhibits Glycolysis of Prostate Cancer Through Inhibition of the MYC-LDHA Axis. Onco Targets Ther 13:8771\u20138782. https:\/\/doi.org\/10.2147\/OTT.S258724","journal-title":"Onco Targets Ther"},{"key":"5776_CR34","doi-asserted-by":"publisher","first-page":"176007","DOI":"10.1016\/j.ejphar.2023.176007","volume":"957","author":"Y Yu","year":"2023","unstructured":"Yu Y, Huang X, Liang C, Zhang P (2023) Evodiamine impairs HIF1A histone lactylation to inhibit Sema3A-mediated angiogenesis and PD-L1 by inducing ferroptosis in prostate cancer. Eur J Pharmacol 957:176007. https:\/\/doi.org\/10.1016\/j.ejphar.2023.176007","journal-title":"Eur J Pharmacol"},{"key":"5776_CR35","doi-asserted-by":"publisher","first-page":"112033","DOI":"10.1016\/j.celrep.2023.112033","volume":"42","author":"Y He","year":"2023","unstructured":"He Y, Ji Z, Gong Y, Fan L, Xu P, Chen X, Miao J, Zhang K, Zhang W, Ma P, Zhao H, Cheng C, Wang D, Wang J, Jing N, Liu K, Zhang P, Dong B, Zhuang G, Fu Y, Xue W, Gao WQ, Zhu HH (2023) Numb\/Parkin-directed mitochondrial fitness governs cancer cell fate via metabolic regulation of histone lactylation. Cell Rep 42:112033. https:\/\/doi.org\/10.1016\/j.celrep.2023.112033","journal-title":"Cell Rep"},{"key":"5776_CR36","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/nrurol.2012.116","volume":"9","author":"RM Kypta","year":"2012","unstructured":"Kypta RM, Waxman J (2012) Wnt\/beta-catenin signalling in prostate cancer. Nat Rev Urol 9:418\u2013428. https:\/\/doi.org\/10.1038\/nrurol.2012.116","journal-title":"Nat Rev Urol"},{"key":"5776_CR37","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.2147\/OTT.S102862","volume":"9","author":"K Han","year":"2016","unstructured":"Han K, Meng W, Zhang JJ, Zhou Y, Wang YL, Su Y, Lin SC, Gan ZH, Sun YN, Min DL (2016) Luteolin inhibited proliferation and induced apoptosis of prostate cancer cells through miR-301. Onco Targets Ther 9:3085\u20133094. https:\/\/doi.org\/10.2147\/OTT.S102862","journal-title":"Onco Targets Ther"},{"key":"5776_CR38","doi-asserted-by":"publisher","first-page":"e52279","DOI":"10.1371\/journal.pone.0052279","volume":"7","author":"P Pratheeshkumar","year":"2012","unstructured":"Pratheeshkumar P, Son YO, Budhraja A, Wang X, Ding S, Wang L, Hitron A, Lee JC, Kim D, Divya SP, Chen G, Zhang Z, Luo J, Shi X (2012) Luteolin inhibits human prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis. PLoS ONE 7:e52279. https:\/\/doi.org\/10.1371\/journal.pone.0052279","journal-title":"PLoS ONE"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05776-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05776-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05776-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:15:30Z","timestamp":1792077330000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05776-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":38,"alternative-id":["5776"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05776-8","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]},"assertion":[{"value":"26 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The procedures were approved by the Committee on the Ethics of Animal Experiments of Nanjing University of Chinese Medicine (202403A074, 202311A028, 202409A021 and 202409A026).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}